+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Familial predisposition to breast cancer. Review



Familial predisposition to breast cancer. Review



Investigacion Clinica 39(1): 53-65



An estimated 20% of all breast cancer or ovarian and breast cancer cases have familial aggregation. Today it is known that approximately 10% of these cases are attributable to inherited mutations of a predisposition gene that confers a high risk of developing the disease. Several genes have been identified that differ in the risks which they determine, the proportion of cases they explain and the other cancers they may cause. Out of all the genes reported so far, BRCA1 and BRCA2 are the most important ones. The mutations in the remaining genes are rare or involve moderate or low risks. The possibility to detect breast and/or ovarian cancer susceptibility genes in high risk families poses serious challenges that must be faced by health professionals related with this field.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046073916

Download citation: RISBibTeXText

PMID: 9586400


Related references

The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators. Cancer Research 60(16): 4513-4518, 2000

Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Research and Treatment 95(1): 73-80, 2006

Genetic predisposition to cancer: familial forms of medullary thyroid cancer and breast cancer. Bulletin de l'Academie Nationale de Medecine 178(1): 123-9; Discussion 129-32, 1994

Mitochondria and familial predisposition to breast cancer. Current Genomics 14(3): 195-203, 2013

Evaluation of RAD50 in familial breast cancer predisposition. International Journal of Cancer 118(11): 2911-2916, 2006

Epidemiology of familial predisposition for breast cancer in Japan. Journal of the National Cancer Institute 69(6): 1229-1234, 1982

Can unknown predisposition in familial breast cancer be family-specific?. Breast Journal 19(5): 520-528, 2014

The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. Cancer Research 60(16): 4513-4518, 2000

Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. International Journal of Cancer 86(6): 883-887, 15 June, 2000

Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Cancer Research 63(24): 8596-8599, 2003

Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition. Breast 15(5): 673-676, 2006

Re. Multimodality breast cancer screening in women with a familial or genetic predisposition. Current Oncology 17(6): 4-5, 2010

Multimodality breast cancer screening in women with a familial or genetic predisposition. Current Oncology 17(3): 28-36, 2010

Familial predisposition to breast cancer in a British population: Implications for prevention. European Journal of Cancer 36(6): 773-779, 2000